Mouse models of glucose sensor biocompatibility

Diabetes Technology and Therapeutics

Volumn 7, Issue 5, 2005, Pages 738-740

  Friedl, Karl E ^a  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; POLITEF; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCOMPATIBILITY; BIOSENSOR; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; EXPERIMENTATION; GLUCOSE BLOOD LEVEL; IMPLANT; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; TECHNOLOGY;

EID: 27644491314     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2005.7.738     Document Type: Note

References (10)

1. Rayl AJS: From implants to explants, and beyond-multidisciplinary panel emphasizes follow-up research. Scientist 2000;14:16.
2. Klueh U, Kreutzer DL: Murine model of implantable glucose sensors: A novel model for glucose sensor development. Diabetes Technol Ther 2005;7:727-737.
3. Mang A, Pill J, Gretz N, Kranzlin B, Buck H, Schoemaker M, Petrich W: Biocompatibility of an electrochemical sensor for continuous glucose monitoring in subcutaneous tissue. Diabetes Technol Ther 2005;7:163-173.
4. Mills PA, Huetteman DA, Brockway BP, Zwers LM, Gelsema AJM, Schwartz RS, Kramer K: A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry. J Appl Physiol 2000;88:1537-1544.
5. Kidd KR, Dal Ponte DB, Kellar RS, Williams SK: A comparative evaluation of the tissue responses associated with polymeric implants in the rat and mouse. J Biomed Mater Res 2001;59:682-689.
6. Wisniewski N, Rajamand N, Adamsson U, Lins PE, Reichert WM, Klitzman B, Ungerstedt U: Analyte flux through chronically implanted subcutaneous polyamide membranes differs in humans and rats. Am J Physiol Endocrinol Metab 2002;282:E1316-E1323.
7. Schwartz MA, Stone AL, Greer KA, Hoying JB, Williams SK: Gene expression in tissue associated with extracellular matrix modified ePTFE. J Biomed Mater Res A 2005;73:30-38.
8. Klueh U, Dorsky DI, Kreutzer DL: Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. Biomaterials 2005;26:1155-1163.
9. Ward WK, Wood MD, Casey HM, Quinn MJ, Federiuk IF: The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically implanted amperometric glucose sensor. Diabetes Technol Ther 2004;6:137-145.
10. Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD: Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 2004;25:2789-2798.